Literature DB >> 1728259

Evaluation of cerebral biopsies for the diagnosis of dementia.

C M Hulette1, N L Earl, B J Crain.   

Abstract

To identify those patients most likely to benefit from a cerebral biopsy to diagnose dementia, we reviewed a series of 14 unselected biopsies performed during a 9-year period (1980 through 1989) at Duke University Medical Center, Durham, NC. Pathognomonic features allowed a definitive diagnosis in seven specimens. Nondiagnostic abnormalities but not diagnostic neuropathologic changes were seen in five additional specimens, and two specimens were normal. Creutzfeldt-Jakob disease was the most frequent diagnosis. One patient each was diagnosed as having Alzheimer's disease, diffuse Lewy body disease, adult-onset Niemann-Pick disease, and anaplastic astrocytoma. We conclude that a substantial proportion of patients presenting clinically with atypical dementia are likely to receive a definitive diagnosis from a cerebral biopsy. However, in those with coexisting hemiparesis, chorea, athetosis, or lower motor neuron signs, cerebral biopsies are less likely to be diagnostic.

Entities:  

Mesh:

Year:  1992        PMID: 1728259     DOI: 10.1001/archneur.1992.00530250032011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

2.  Biopsy of the superficial cortex: predictors of effectiveness and outcomes.

Authors:  Ammar H Hawasli; Robert T Buckley; Feng Gao; David D Limbrick; Matthew D Smyth; Jeffrey R Leonard; Paul Santiago; Todd J Stewart; Tae S Park; Robert L Grubb; Joshua L Dowling; Eric C Leuthardt; Keith M Rich; Gregory J Zipfel; Ralph G Dacey; Michael R Chicoine
Journal:  Neurosurgery       Date:  2013-08       Impact factor: 4.654

3.  Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups.

Authors:  Andrew King; Satomi Maekawa; Istvan Bodi; Claire Troakes; Olimpia Curran; Keyoumars Ashkan; Safa Al-Sarraj
Journal:  Acta Neuropathol Commun       Date:  2013-08-19       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.